These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 25262802)

  • 1. Anthrax lethal factor inhibitors as potential countermeasure of the infection.
    Kumar BV; Malik S; Grandhi P; Dayam R; Sarma JA
    Curr Top Med Chem; 2014; 14(17):1977-89. PubMed ID: 25262802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anthrax toxin: a tripartite lethal combination.
    Ascenzi P; Visca P; Ippolito G; Spallarossa A; Bolognesi M; Montecucco C
    FEBS Lett; 2002 Nov; 531(3):384-8. PubMed ID: 12435580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The anthrax lethal factor and its MAPK kinase-specific metalloprotease activity.
    Tonello F; Montecucco C
    Mol Aspects Med; 2009 Dec; 30(6):431-8. PubMed ID: 19665472
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anthrax toxin.
    Bhatnagar R; Batra S
    Crit Rev Microbiol; 2001; 27(3):167-200. PubMed ID: 11596878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Consequences and utility of the zinc-dependent metalloprotease activity of anthrax lethal toxin.
    Bromberg-White J; Lee CS; Duesbery N
    Toxins (Basel); 2010 May; 2(5):1038-53. PubMed ID: 22069624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low molecular weight inhibitors of the protease anthrax lethal factor.
    Dalkas GA; Papakyriakou A; Vlamis-Gardikas A; Spyroulias GA
    Mini Rev Med Chem; 2008 Mar; 8(3):290-306. PubMed ID: 18336349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Purified Bacillus anthracis lethal toxin complex formed in vitro and during infection exhibits functional and biological activity.
    Panchal RG; Halverson KM; Ribot W; Lane D; Kenny T; Abshire TG; Ezzell JW; Hoover TA; Powell B; Little S; Kasianowicz JJ; Bavari S
    J Biol Chem; 2005 Mar; 280(11):10834-9. PubMed ID: 15644338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blocking anthrax lethal toxin at the protective antigen channel by using structure-inspired drug design.
    Karginov VA; Nestorovich EM; Moayeri M; Leppla SH; Bezrukov SM
    Proc Natl Acad Sci U S A; 2005 Oct; 102(42):15075-80. PubMed ID: 16214885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of toxin functional domains in anthrax pathogenesis.
    Brossier F; Weber-Levy M; Mock M; Sirard JC
    Infect Immun; 2000 Apr; 68(4):1781-6. PubMed ID: 10722564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of small molecule inhibitors of anthrax lethal factor.
    Panchal RG; Hermone AR; Nguyen TL; Wong TY; Schwarzenbacher R; Schmidt J; Lane D; McGrath C; Turk BE; Burnett J; Aman MJ; Little S; Sausville EA; Zaharevitz DW; Cantley LC; Liddington RC; Gussio R; Bavari S
    Nat Struct Mol Biol; 2004 Jan; 11(1):67-72. PubMed ID: 14718925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anthrax Pathogenesis.
    Moayeri M; Leppla SH; Vrentas C; Pomerantsev AP; Liu S
    Annu Rev Microbiol; 2015; 69():185-208. PubMed ID: 26195305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insights into the anthrax lethal factor-substrate interaction and selectivity using docking and molecular dynamics simulations.
    Dalkas GA; Papakyriakou A; Vlamis-Gardikas A; Spyroulias GA
    Protein Sci; 2009 Aug; 18(8):1774-85. PubMed ID: 19585464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toxins of Bacillus anthracis.
    Brossier F; Mock M
    Toxicon; 2001 Nov; 39(11):1747-55. PubMed ID: 11595637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Probing the S2' Subsite of the Anthrax Toxin Lethal Factor Using Novel N-Alkylated Hydroxamates.
    Kurbanov EK; Chiu TL; Solberg J; Francis S; Maize KM; Fernandez J; Johnson RL; Hawkinson JE; Walters MA; Finzel BC; Amin EA
    J Med Chem; 2015 Nov; 58(21):8723-33. PubMed ID: 26492514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Anthrax toxins].
    Brossier F; Guidi-Rontani C; Mock M
    C R Seances Soc Biol Fil; 1998; 192(3):437-44. PubMed ID: 9759382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular dynamics simulations of complexes between wild-type and mutant anthrax protective antigen variants and a model anthrax toxin receptor.
    Stiles L; Nelson DJ
    J Biomol Struct Dyn; 2005 Apr; 22(5):503-19. PubMed ID: 15702923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anthrax lethal factor inhibition.
    Shoop WL; Xiong Y; Wiltsie J; Woods A; Guo J; Pivnichny JV; Felcetto T; Michael BF; Bansal A; Cummings RT; Cunningham BR; Friedlander AM; Douglas CM; Patel SB; Wisniewski D; Scapin G; Salowe SP; Zaller DM; Chapman KT; Scolnick EM; Schmatz DM; Bartizal K; MacCoss M; Hermes JD
    Proc Natl Acad Sci U S A; 2005 May; 102(22):7958-63. PubMed ID: 15911756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Manipulation of host signalling pathways by anthrax toxins.
    Turk BE
    Biochem J; 2007 Mar; 402(3):405-17. PubMed ID: 17313374
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anthrax lethal factor and edema factor act on conserved targets in Drosophila.
    Guichard A; Park JM; Cruz-Moreno B; Karin M; Bier E
    Proc Natl Acad Sci U S A; 2006 Feb; 103(9):3244-9. PubMed ID: 16455799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anthrax toxin lethal factor domain 3 is highly mobile and responsive to ligand binding.
    Maize KM; Kurbanov EK; De La Mora-Rey T; Geders TW; Hwang DJ; Walters MA; Johnson RL; Amin EA; Finzel BC
    Acta Crystallogr D Biol Crystallogr; 2014 Nov; 70(Pt 11):2813-22. PubMed ID: 25372673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.